T1	p 137 170	after major gynecologic surgery .
T2	p 349 429	360 ASA physical status I-III patients undergoing total abdominal hysterectomy (
T3	p 434 437	) .
T4	p 713 717	four
T5	p 773 784	hypotension
T6	p 881 882	.
T7	p 901 920	patients developing
T8	p 1135 1143	received
T9	i 22 95	prophylactic ondansetron , droperidol , perphenazine , and metoclopramide
T10	i 169 170	.
T11	i 211 293	intravenous ( i.v . ) ondansetron , droperidol , perphenazine , and metoclopramide
T12	i 349 356	360 ASA
T13	i 405 437	abdominal hysterectomy ( TAH ) .
T14	i 474 478	i.v.
T15	i 488 504	ondansetron 4 mg
T16	i 507 581	droperidol 1.25 mg , perphenazine 5 mg , metoclopramide 10 mg , or placebo
T17	i 615 616	.
T18	i 665 679	metoclopramide
T19	i 733 744	ondansetron
T20	i 855 865	droperidol
T21	i 1044 1055	prophylaxis
T22	i 1069 1086	antiemetic rescue
T23	i 1148 1161	. ondansetron
T24	i 1173 1183	droperidol
T25	i 1195 1213	and perphenazine (
T26	i 1255 1262	placebo
T27	i 1285 1299	Metoclopramide
T28	i 1327 1338	ondansetron
T29	i 1341 1370	droperidol , and perphenazine
T30	i 1410 1421	prophylaxis
T31	i 1433 1447	. perphenazine
T32	i 1500 1512	perphenazine
T33	i 1565 1570	TAH .
T34	o 117 136	nausea and vomiting
T35	o 175 207	prophylactic antiemetic efficacy
T36	o 617 628	Hypotension
T37	o 764 784	systolic hypotension
T38	o 873 882	sedated .
T39	o 921 961	severe nausea , retching , or vomiting ,
T40	o 973 986	severe emetic
T41	o 1069 1088	antiemetic rescue .
T42	o 1112 1118	number
T43	o 1457 1472	of side effects